Patent details

EP4031133 Title: PYRUVATE KINASE R (PKR) ACTIVATING COMPOSITIONS

Basic Information

Publication number:
EP4031133
PCT Application Number:
US2020051645
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP208659250
PCT Publication Number:
WO2021055863
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
PYRUVATE KINASE R (PKR) ACTIVATING COMPOSITIONS
French Title of Invention:
COMPOSITIONS D'ACTIVATION DE LA PYRUVATE KINASE R (PKR)
German Title of Invention:
PYRUVATKINASE R (PKR)-AKTIVIERUNGSZUSAMMENSETZUNGEN
SPC Number:

Dates

Filing date:
18/09/2020
Grant date:
13/08/2025
EP Publication Date:
27/07/2022
PCT Publication Date:
25/03/2021
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
13/08/2025
EP B1 Publication Date:
13/08/2025
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
18/09/2040
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
06/08/2025
 
 

Name:
Novo Nordisk Health Care AG
Address:
The Circle 32 8058 Zürich, Switzerland (CH)

Inventor

1

Name:
SHETH, Pratik
Address:
United States (US)

2

Name:
MITCHELL MINIKIS, Ryan
Address:
United States (US)

3

Name:
TALADI, Vijay
Address:
United States (US)

4

Name:
BABU, Suresh
Address:
United States (US)

Priority

1

Priority Number:
201916576720
Priority Date:
19/09/2019
Priority Country:
United States (US)

2

Priority Number:
PCT/US2019/052024
Priority Date:
19/09/2019
Priority Country:
World Intellectual Property Office (WIPO) (WO)

3

Priority Number:
201916576360
Priority Date:
19/09/2019
Priority Country:
United States (US)

4

Priority Number:
201962902887 P
Priority Date:
19/09/2019
Priority Country:
United States (US)

5

Priority Number:
201962906437 P
Priority Date:
26/09/2019
Priority Country:
United States (US)

6

Priority Number:
202063024441 P
Priority Date:
13/05/2020
Priority Country:
United States (US)

7

Priority Number:
202063024432 P
Priority Date:
13/05/2020
Priority Country:
United States (US)

8

Priority Number:
202062704785 P
Priority Date:
28/05/2020
Priority Country:
United States (US)

9

Priority Number:
202062705106 P
Priority Date:
11/06/2020
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/407; A61K 31/436; A61P 7/06; C07D 487/04; A61K 9/00; A61K 9/16; A61K 9/20; C07D 519/00;

Publication

European Patent Bulletin

Issue number:
202533
Publication date:
13/08/2025
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
13/10/2025
Annual Fee Number:
6
Annual Fee Amount:
66 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages